Tag: biologic drugs

Future Biosimilars: The 2025-2030 Patent Cliff and Market Entry Guide

Explore the upcoming wave of biosimilar market entries as major biologic patents expire between 2025 and 2030. Learn about Keytruda, Eylea, and the cost savings for patients.